Previous 10 | Next 10 |
SAN DIEGO, March 16, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company focused on developing and commercializing products in various therapeutic areas, including opioid overdose, allergy, respiratory and inflammatory disease, today announc...
2023-03-14 08:38:09 ET Adamis Pharmaceuticals ( NASDAQ: ADMP ) shares fell 5% premarket on Tuesday after the biopharmaceutical company launched a securities offering to raise $3M in gross proceeds. The firm entered into a securities purchase agreement with a single ins...
SAN DIEGO, March 14, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company primarily focused on developing and commercializing products in various therapeutic areas, including opioid overdose, allergy, respiratory and inflammatory...
NEW YORK, NY / ACCESSWIRE / March 5, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: INDUS Realty Trust, Inc. (NASDAQ: IND...
NEW YORK, NY / ACCESSWIRE / March 2, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Ranger Oil Corporation (NASDAQ:ROCC)'...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Wirestock Creators / Shutterstock Clover Health (NASDAQ: CLOV ) stock is on the rise Tuesday thanks to the company’s earnings report for the fourth quarter of 2022. One of the biggest factors that h...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Tada Images / Shutterstock.com Digital World Acquisition (NASDAQ: DWAC ) stock is on the move Tuesday after the company announced a new deadline for June 8, 2023 . That new deadline is how long the compan...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: shutterstock.com/Champhei It’s an unusual day for Adamis Pharmaceuticals (NASDAQ: ADMP ) stock traders, to say the least. That’s because the company recently announced its intent to acquire DMK ...
Specialty biopharmaceutical company focused on developing and commercializing products in various therapeutic areas, including opioid overdose, allergy, respiratory and inflammatory disease Adamis Pharmaceuticals ( ADMP ) and DMK Pharmaceuticals plan a merger . DMK...
Combined company will have commercial products and a library of development candidates, two of which are clinical stage Will be under the leadership of DMK CEO, Dr. Ebrahim (Eboo) Versi MD, PhD Lead development program will be a clinical stage therapeutic under development for the...
News, Short Squeeze, Breakout and More Instantly...
Adamis Pharmaceuticals Corporation Company Name:
ADMP Stock Symbol:
NASDAQ Market:
Adamis Pharmaceuticals Corporation Website:
SAN DIEGO, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced the company changed its name to DMK Pharmaceuticals Corporation in order to better reflect its new strategic focus on advancing sm...
SAN DIEGO, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced financial results for the second quarter ended June 30, 2023, and provided an update on recent corporate developments. Q2 2023 ...
SAN DIEGO, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced the closing of its public offering of 5,930,000 units, with each unit consisting of one share of common stock (or pre-funded warrant in...